Assessing Pubertal Suppression with 3.75 mg Monthly Versus 11.25 mg 3-Monthly Leuprolide Acetate in Girls with Central Precocious Puberty
{{output}}
Objective: Gonadotropin-releasing hormone analogs (GnRHa), such as leuprolide acetate (LA), are standard treatments for central precocious puberty (CPP). This study compared the effectiveness of the monthly 3.75 mg and 3-monthly ... ...
